Paul Hastings | BiotechTV

top of page

Search

Nkarta CEO Paul Hastings on NK based cell therapies for autoimmune conditions

Nkarta CEO Paul Hastings on NK based cell therapies for autoimmune conditions

Nkarta CEO Paul Hastings on NK based cell therapies for autoimmune conditions

Paul Hastings describes why Nkarta believes NK based therapies are uniquely fit for this area.

Mar 27, 2024

BIO Chairman and Nkarta CEO talks biotech

BIO Chairman and Nkarta CEO talks biotech

BIO Chairman and Nkarta CEO talks biotech

Current BIO Chairman and Nkarta CEO Paul Hastings talks about the policy changes that have been affecting biotech lately, and NK cells.

Apr 28, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page